Opko Health (OPK) Change in Accured Expenses (2010 - 2026)
Opko Health's (OPK) quarterly Change in Accured Expenses came in at -$8.3 million in Q2 2026, up 65.73% YoY from -$5.0 million in Q2 2025, and down 1.81% on a QoQ basis from -$8.2 million in Q1 2026.
Opko Health (OPK) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Opko Health (OPK) has 17 years of Change in Accured Expenses data on file, last reported at -$8.3 million in Q2 2026.
- Quarterly Change in Accured Expenses rose 65.73% year-over-year to -$8.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$20.7 million (down 535.3% YoY) and the FY2025 annual result came in at -$47.8 million, down 198.27% from the prior year.
- Change in Accured Expenses declined to -$8.3 million in Q2 2026, from -$8.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $45.0 million in Q3 2024 to a low of -$36.2 million in Q1 2022.
- A 5-year average of -$6.7 million and a median of -$8.2 million in 2026 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses soared 794.75% — and 2025, when it tumbled 1752.63%.
- Tracing OPK's Change in Accured Expenses over 5 years: stood at -$8.5 million in 2022, then slumped by 83.68% to -$15.6 million in 2023, then jumped by 388.63% to $45.0 million in 2024, then sank by 108.4% to -$3.8 million in 2025, then sank by 120.07% to -$8.3 million in 2026.
- The last three Change in Accured Expenses figures came in at -$8.3 million (Q2 2026), -$8.2 million (Q1 2026), and -$3.8 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -48.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 142.00 Mn |
| 10 | Opko Health | 1.02 Bn | 718.85 Mn | 80.02 Mn | -8.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.31 Mn |
| Jun 30, 2026 | -8.31 Mn |
| Mar 31, 2026 | -8.16 Mn |
| Mar 31, 2026 | -8.16 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Sep 30, 2025 | -420,000.00 |
| Sep 30, 2025 | -420,000.00 |
| Jun 30, 2025 | -24.25 Mn |
| Jun 30, 2025 | -24.25 Mn |
| Mar 31, 2025 | -19.40 Mn |
| Mar 31, 2025 | -19.40 Mn |
| Sep 30, 2024 | 44.95 Mn |
| Sep 30, 2024 | 44.95 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -15.57 Mn |
| Dec 31, 2023 | -15.57 Mn |